Rosanna Missione

CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab

G. Marfia, D. Landi, P. Cavalla, 2021, International journal of environmental research and public health.

Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study

D. Centonze, G. Marfia, C. Pozzilli, 2022, Neurology and Therapy.